Operating Lease, Right-of-Use Asset of ENZO BIOCHEM INC from 01 Aug 2019 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ENZO BIOCHEM INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Aug 2019 to 30 Apr 2025.
  • ENZO BIOCHEM INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Apr 2025 was $2,472,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ENZO BIOCHEM INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,472,000 -$487,000 -16% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 $2,563,000 -$624,000 -20% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q2
Q3 2024 $2,654,000 -$751,000 -22% 31 Oct 2024 10-Q 16 Dec 2024 2025 Q1
Q2 2024 $2,836,000 -$790,000 -22% 31 Jul 2024 10-Q 16 Jun 2025 2025 Q3
Q1 2024 $2,959,000 -$10,498,000 -78% 30 Apr 2024 10-Q 13 Jun 2024 2024 Q3
Q4 2023 $3,187,000 -$10,382,000 -77% 31 Jan 2024 10-Q 13 Mar 2024 2024 Q2
Q3 2023 $3,405,000 -$11,014,000 -76% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q1
Q2 2023 $3,626,000 -$758,000 -17% 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 $13,457,000 -$1,505,000 -10% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q3
Q4 2022 $13,569,000 -$1,838,000 -12% 31 Jan 2023 10-Q 20 Mar 2023 2023 Q2
Q3 2022 $14,419,000 -$1,840,000 -11% 31 Oct 2022 10-Q 12 Dec 2022 2023 Q1
Q2 2022 $4,384,000 -$12,636,000 -74% 31 Jul 2022 10-K 03 Nov 2023 2023 FY
Q1 2022 $14,962,000 -$2,449,000 -14% 30 Apr 2022 10-Q 09 Jun 2022 2022 Q3
Q4 2021 $15,407,000 -$3,052,000 -17% 31 Jan 2022 10-Q 14 Mar 2022 2022 Q2
Q3 2021 $16,259,000 -$3,057,000 -16% 31 Oct 2021 10-Q 15 Dec 2021 2022 Q1
Q2 2021 $17,020,000 -$2,896,000 -15% 31 Jul 2021 10-K 14 Oct 2022 2022 FY
Q1 2021 $17,411,000 -$3,401,000 -16% 30 Apr 2021 10-Q 11 Jun 2021 2021 Q3
Q4 2020 $18,459,000 -$3,554,000 -16% 31 Jan 2021 10-Q 16 Mar 2021 2021 Q2
Q3 2020 $19,316,000 -$3,885,000 -17% 31 Oct 2020 10-Q 11 Dec 2020 2021 Q1
Q2 2020 $19,916,000 -$4,484,000 -18% 31 Jul 2020 10-K 12 Oct 2021 2021 FY
Q1 2020 $20,812,000 30 Apr 2020 10-Q 09 Jun 2020 2020 Q3
Q4 2019 $22,013,000 31 Jan 2020 10-Q 06 Mar 2020 2020 Q2
Q3 2019 $23,201,000 31 Oct 2019 10-Q 10 Dec 2019 2019 Q1
Q2 2019 $24,400,000 01 Aug 2019 10-K 12 Oct 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.